1. Overview

The American Heart Association International Stroke Conference OnDemand 2023 is a leading global forum highlighting the latest advancements, clinical trials, and emerging technologies in cerebrovascular disease. The program encompasses diverse topics, from acute stroke interventions and thrombectomy techniques to secondary prevention, health equity, and advanced post-stroke rehabilitation.

Course Date: 2023

2. Learning Objectives

• Evaluate late-breaking clinical trials and their implications for acute stroke interventions and medical management.

• Implement advanced neuroendovascular techniques, including thrombectomy and aneurysm treatments, for complex cerebrovascular cases.

• Analyze the impact of systemic factors, such as atrial fibrillation, social determinants, and sex differences, on stroke risks and outcomes.

• Assess innovations in digital health, AI integration, and multimodality imaging in the diagnosis and monitoring of stroke patients.

• Develop comprehensive post-stroke care strategies, emphasizing rehabilitation, cognitive recovery, and secondary prevention therapies.

3. Target Audience

Best for neurologists, neurosurgeons, and stroke care specialists who want updates on neurointerventions, clinical trials, and rehabilitation.

4. Topics

1. 2023 Paola De Rango Memorial Session on Stroke in Women Social Factors Contributing to Sex Differences in Short and Long-Term Outcomes

2. A Paradigm Shift Novel Approaches for Chronic Subdural Hematoma

3. Achieving More Rapid Reperfusion in Contemporary Emergency Care

4. Acute Care

5. Acute Stroke Treatment and Prevention in the Elderly Evidence and Beyond

6. Acute Treatment Systemic Thrombolysis and Cerebroprotection Oral Abstracts

7. Advanced Practice Providers and Therapists Oral Abstracts

8. Advances in Neurocardiology Atrial Fibrillation Atrial Cardiopathy and Beyond

9. Advances in NeuroCardiology Using technology to optimize secondary stroke prevention

10. Aneurysms and Vascular Malformations Oral Abstracts I

11. Aneurysms and Vascular Malformations Oral Abstracts II

12. ASAtv Now – Friday Morning 1

13. ASAtv Now – Friday Morning 2

14. ASAtv Now – Thursday Afternoon

15. ASAtv Now – Thursday Mid-Day

16. ASAtv Now – Thursday Morning

17. ASAtv Now – Wednesday Mid-Day 2

18. ASAtv Now – Wednesday Mid-Day

19. ASAtv Now – Wednesday Morning

20. Benefits of End to End Clot Control

21. Brain Health Oral Abstracts I

22. Brain Health Oral Abstracts II

23. Bridging Therapy for EVT Following Recent Trials Can We Personalize Treatment Debate

24. Bugher Foundation Session

25. Care Across the Continuum

26. Cases in AF monitoring Who when and for how long

27. Cerebrovascular Complications of Cardiac Devices and Procedures

28. Cerebrovascular Complications of Infectious Endocarditis

29. Cerebrovascular Manifestations of COVID-19 Oral Abstracts

30. Cerebrovascular Nursing Oral Abstracts

31. Cerebrovascular Systems of Care Oral Abstracts

32. Clinical Rehabilitation and Recovery Oral Abstracts

33. Closing Main Event

34. Cognitive Recovery after Stroke A Stroke Journal Session

35. Complexities and Complications Lessons In Training Trainee Case Studies Session 1

36. Complexities and Complications Lessons In Training Trainee Case Studies Session 2

37. Concept to Cure Translating Your Ideas into Therapies

38. Congenital Heart Disease and Stroke Risk In Children And Adults

39. Controversies in Carotid Artery Disease Debates

40. Controversies in Secondary Stroke Prevention in Patients with Atrial fibrillation Debate

41. Determining Neurovascular Pathophysiology Essential APP Knowledge and Skills

42. Diagnosis and Management of Symptomatic Non-Stenotic Carotids

43. Endovascular Thrombectomy in Special Populations

44. Endovascular Thrombectomy Platform Trial Why How and What an AHAUS Government Agency Joint Symposia

45. Expanding Prehospital Indications for Mobile Stroke Units

46. Factors Influencing Stroke Recovery

47. Focused Review of Stroke Scientific Statements and Guidelines

48. Friend or Foe Analytic Complexity Risks and Benefits of Using Clinical Imaging or Patient Reported Surrogate Outcomes in Clinical Trials

49. From Bench to Bedside and Beyond Acute and Chronic Neuroinflammation in Stroke Potential Targets for Novel Therapies

50. From Bench to Bedside and Beyond Modern Perspectives in Cerebral Amyloid Angiopathy

51. From Bench to Bedside and Beyond Sickle Cell Disease and Stroke Risk Across the Lifespan and Research Spectrum

52. From Clinical Trials to Patient Implementation Methods for Incorporating State of the Science Stroke Research into APP Clinical Practice

53. Game of Strokes

54. Genetics of Stroke Risk and Prevention

55. HEADS-UP Health Equity and Actionable Disparities in Stroke Understanding and Problem-solving

56. Health Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts I

57. Health Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts II

58. Health Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts III

59. Hypertensive Arteriolosclerosis Common but Understudied

60. Ideal Foundational Requirements for Stroke Program Development and Growth

61. Identifying Genetic Factors that Impact Stroke Outcome in Mice and Humans

62. Imaging Oral Abstracts I

63. Imaging Oral Abstracts II

64. Improvement in Motor Performance Post-Stroke Across the Care Pathway

65. Influence of Early-Life Vascular Risks on Cognition and Functional and Structural Brain Changes

66. In-Hospital Care from the ICU to Discharge Oral Abstracts

67. Inside the AHAs Research Enterprise Grant Funding and Other Opportunities

68. International Alliance Overcoming the Burden of Stroke in Lower Resource Locations

69. Intersections of COVID-19 with Cerebrovascular Disease

70. Intracerebral Hemorrhage Oral Abstracts

71. Intracranial Atherosclerotic Disease after SAMMPRIS Looking to the Future after a Lost Decade

72. ISC Innovation Showcase

73. Joint AHASVIN Session

74. Large Vessel Disease from Arteries to Veins Non-Acute Treatment Oral Abstracts

75. Late-Breaking Science Oral Abstracts I

76. Late-Breaking Science Oral Abstracts II

77. Late-Breaking Science Oral Abstracts III

78. Left Atrial Appendage Closure and the Heart-Brain Impact

79. Listen Carefully New and Old Ultrasound Tools for Stroke Diagnosis and Prevention

80. Maintaining Legacy and Exploring Distal Frontiers

81. Management of Factor-Xa Inhibitor Related Life-Threatening or Uncontrolled Bleeding

82. Meet the Expert 1 Neuromodulation

83. Meet the Expert 2 Stroke-related Cognitive Impairment

84. Meet the Expert 3 Genetics

85. Meet the Expert 4 Novel Treatment of ICH

86. Multimodality Monitoring in Coma and Disorders of Consciousness after Stroke an ASA and Neurocritical Care Society Joint Session

87. Neuroendovascular Oral Abstracts I

88. Neuroendovascular Oral Abstracts II

89. Neuroendovascular Oral Abstracts III

90. Novel Prehospital Stroke Triage Approaches Ready for Prime Time Debates

91. Opening Main Event

92. Paracrine Protection of Neurons by Astrocytes in Ischemic Stroke

93. Pediatric Cerebrovascular Disease Oral Abstracts

94. Pediatric Stroke Emerging Therapies From Acute Care to Rehabilitation

95. Perfusion and Collaterals in the Ischemic Penumbra

96. Pre-Clinical Translational Stroke Development SPAN Results and Next Steps

97. Public Health Interventions in Increasing Global Access to Reperfusion Therapy

98. Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke

99. Risk Factors and Prevention Oral Abstracts I

100. Risk Factors and Prevention Oral Abstracts II

101. Risk Factors and Prevention Oral Abstracts III

102. State-of-the-Science Stroke Nursing Symposium Main Event

103. Strength in Numbers Largest multicenter experience with Pipeline Flex with Shield Technology

104. Stroke Certification Program for Non-US Countries The WSO Experience a Joint AHA World Stroke Organization Session

105. Stroke Coordinator Super Session

106. Stroke in the Lab World High-Dimensional Single Cell Analyses to Unravel the Complexities of Cerebrovascular Disease and Brain Health

107. Stroke in the Real World

108. Stroke Program Optimization

109. Subarachnoid Hemorrhage

110. Technological Advances in Rehabilitation Lead to Improved Outcomes

111. The Need for Women Specific Clinical Trials in Stroke Prevention

112. The Next Frontiers in Mobile Stroke Unit Practice and Implementation

113. The Road to Tenecteplase in Routine Clinical Practice

114. The What and When of Critical Aneurysm Treatments Current Debates

115. Thrombolysis in Acute Ischemic Stroke Yesterday Today and Tomorrow

116. Thursday Main Event

117. Translational Basic Science Oral Abstracts I

118. Translational Basic Science Oral Abstracts II

119. Translational Basic Science Oral Abstracts III

120. Treating Intracranial Aneurysms Balancing Efficacy Costs and Innovation

121. Vagus Nerve Stimulation for Stroke Recovery To Implant or Not to Implant Debate

122. What is the True Impact of AI Latest World Data Across Major Stroke Networks

123. Where Is AIML Taking Stroke Diagnosis and Care

124. Who Should We Save A Multi-disciplinary Case-Based Discussion